EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Effect of Etanercept Treatment on the levels of Albumin and C-reactive Protein and their Ratio in Iraqi Psoriatic Patients

Rajaa J. Abdel Rasul, Hathama R. Hasan

Journal of the Faculty of Medicine Baghdad · 01.04.2026 · 68 (1) · 44-51

DOI: 10.32007/jfacmedbaghdad3258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Faculty of Medicine Baghdad, online erschienen am 01.04.2026. Verfasst von Rajaa J. Abdel Rasul und 1 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Psoriasis, a common chronic autoimmune dermatological disease, is identified by scaling and inflammation seen in the skin. Both environmental and genetic factors contribute to its pathogenesis.

Objectives

To examine changes in albumin and C-reactive protein levels and their ratios, and the effect of Etanercept treatment on these indicators in the serum of Iraqi Psoriasis patients compared to healthy individuals.

Methods

A total of 100 Psoriatic patients were enrolled in the study and matched with healthy individuals (n=93) attending the Department of Venereology and Dermatology at Baghdad Teaching Hospital from November 2024 to April 2025. The levels of C-reactive protein and albumin, as well as their ratio in these patients, were compared with those of the control group. Furthermore, the effects of the biologic treatment were followed up for these parameters using 30 patients, before receiving any treatment, and after three months of Etanercept treatment.

Results

The serum level of albumin showed a highly significant decrease, with a highly significant increase in the concentrations of both serum C-reactive protein and the CRP/albumin ratio in the patient group compared to the control group, respectively. Furthermore, the three-month treatment with Etanercept induced a substantial difference in the albumin levels, and a very notable decrease in both C-reactive protein concentration and CRP/albumin ratio.

Conclusion

Psoriasis is a disease that affects the albumin and C-reactive protein levels, as well as their ratio. In the interim, using Etanercept for three months as biotherapy revealed alterations in the measured levels, achieving concentrations nearly similar to those of normal healthy individuals.

Zitieren

APA

Rasul, R. J. A., & Hasan, H. R. (2026). The Effect of Etanercept Treatment on the levels of Albumin and C-reactive Protein and their Ratio in Iraqi Psoriatic Patients. Journal of the Faculty of Medicine Baghdad, 68(1), 44-51. https://doi.org/10.32007/jfacmedbaghdad3258

Vancouver

Rasul RJA, Hasan HR. The Effect of Etanercept Treatment on the levels of Albumin and C-reactive Protein and their Ratio in Iraqi Psoriatic Patients. Journal of the Faculty of Medicine Baghdad. 2026;68(1):44-51. doi:10.32007/jfacmedbaghdad3258

BibTeX
@article{Rasul2026,
  author = {Rasul, Rajaa J. Abdel and Hasan, Hathama R.},
  title = {The Effect of Etanercept Treatment on the levels of Albumin and C-reactive Protein and their Ratio in Iraqi Psoriatic Patients},
  journal = {Journal of the Faculty of Medicine Baghdad},
  year = {2026},
  volume = {68},
  number = {1},
  pages = {44--51},
  doi = {10.32007/jfacmedbaghdad3258}
}
Kostenlos starten →